查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1611199

DNA 診斷市場規模、佔有率、趨勢分析報告：按技術、按應用、按地區、細分市場預測，2025-2030 年

DNA Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR-based Diagnostics, NGS DNA Diagnosis), By Application (Cancer Genetics Tests, Infectious Diseases DNA Testing), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

DNA診斷市場成長與趨勢

Grand View Research, Inc.最新報告顯示，預計2030年全球DNA診斷市場規模將達141.4億美元，2025年至2030年複合年成長率為8.7%。該市場的成長得益於基因組定序的進步和個人化 DNA 水平診斷應用的開發。此外，越來越多的政府資助的專利研究計劃和資助計劃預計將進一步推動市場需求。例如，2022 年 12 月，英國政府宣布提供 2.294 億美元（1.75 億日圓）資金用於高級基因組研究的開發和創建。

基因組分析新技術的採用極大地推動了市場的成長。此外，由於依賴 DNA原型製作透過個人化醫療進行治療和診斷的慢性腫瘤和感染疾病的盛行率不斷增加，預計在預測期內，對 DNA 診斷/測試的研究需求將顯著增加。此外，產前檢測和體外受精需求的成長推動了 DNA 診斷/測試需求的成長，預計這將為市場提供積極的成長前景。 2022年9月，Eurofins Genoma宣布推出niPGT-A，這是一種無胚胎、非侵入性胚胎著床前篩檢測試。

DNA 診斷可以透過次世代定序(NGS) 等技術對腫瘤基因組進行全面分析。 NGS 允許同時對多個基因進行定序，並提供腫瘤中存在的遺傳改變的詳細視圖。透過將腫瘤基因組與正常組織 DNA 進行比較，科學家和臨床醫生可以識別癌細胞特有的突變、拷貝數變異和結構重排。 2022 年 6 月，DNA 定序和基於陣列的技術提供者 Illumina 將宣布與默克合作開發的一項研究測試，旨在深入了解腫瘤基因組。

C型肝炎病毒(HCV) 是一個全球性健康問題，影響著全世界數百萬人。準確、及時的診斷HCV對於有效治療和預防進一步傳播至關重要。在此背景下，DNA 診斷已成為檢測和管理 HCV 感染的強大工具。 2022年7月，羅氏推出了突破性抗原抗體雙重診斷測試Elecsys HCV Duo，支持全球消除C型肝炎病毒的努力。

DNA 診斷市場報告亮點

  • 到2024年，基於PCR的診斷細分市場將佔據最大佔有率，達到49.40%。該細分市場的主導地位歸因於越來越多的主要企業引入基於 PCR 的創新診斷技術，從而導致市場上的廣泛使用和產品可用性的增加。
  • 由於支持全面基因分析的高性能定序技術的進步，預計 NGS DNA 診斷在預測期內將以 13.9% 的複合年成長率快速成長。
  • 癌症基因檢測細分市場佔比最大，2024年將達29.80%。 DNA測序技術擴大用於識別和表徵各種癌症類型和遺傳疾病。
  • 北美DNA診斷市場主導整個全球市場，2024年佔42.72%的銷售佔有率。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 DNA 診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • DNA診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 DNA診斷市場：技術估算與趨勢分析

  • 細分儀表板
  • DNA診斷市場：技術波動分析
  • DNA 診斷市場的技術展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 基於PCR的診斷
  • NGS DNA診斷
  • 原位雜合反應診斷
  • 基於微陣列的診斷
  • 其他

第5章 DNA 診斷市場：按應用、估計和趨勢分析

  • 細分儀表板
  • DNA診斷市場：應用變異分析
  • DNA診斷市場的應用前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 癌症基因檢測
  • 感染疾病DNA檢測
    • 乙型肝炎診斷
    • 結核病診斷
    • CT/NG診斷
    • HPV診斷
    • 耐甲氧西林金黃色葡萄球菌診斷
    • 其他
  • 新生兒基因篩檢
  • 胚胎著床前診斷與生殖診斷
  • 非傳染性疾病的 DNA 檢測
    • 心血管疾病
    • CNS和PNS相關
    • 骨骼、結締組織、外胚層和真皮的 DNA 檢測
    • 肺、腎、肝、消化系統相關
    • 感覺疾病
  • 產前DNA攜帶者篩檢
  • 藥物基因體學/藥物代謝
  • 血液學和免疫學/鑑定和法醫學
  • 其他

第6章 DNA診斷市場：區域估計與趨勢分析

  • 區域儀表板
  • 區域DNA診斷市場波動分析
  • DNA 診斷市場：按技術、生物材料和最終用途進行區域估計和趨勢分析
  • 2018-2030年市場規模、預測及趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 挪威
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 阿根廷
    • 墨西哥
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 市場參與企業分類
  • 公司分類
  • 策略規劃
    • 新產品發布
    • 夥伴關係
    • 獲得
    • 合作
  • 2024年主要企業市場佔有率分析
  • 主要企業簡介
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • QIAGEN
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Hologic, Inc.
    • Agilent Technologies Inc.
    • Siemens Healthineers AG
    • Danaher Corporation
Product Code: 978-1-68038-676-9

DNA Diagnostics Market Growth & Trends:

The global DNA diagnostics market size is expected to reach a value of USD 14.14 billion in 2030 and is projected to grow at a CAGR of 8.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is due to advancements in genome sequencing and the development of personalized DNA-level diagnostic applications. In addition, the rising number of government-sponsored patented research initiatives and funded projects are anticipated to further drive demand in the market. For instance, in December 2022, the UK government announced a funding of USD 229.4 (£175) million for the development and creation of advanced genomic research.

The market growth is highly driven by the introduction of novel technologies for genome profiling. Moreover, with the increasing incidence of chronic oncology and infectious diseases that rely on DNA prototyping for treatment and diagnosis through personalized medicine, the demand for DNA diagnostics/testing-based research is anticipated to increase significantly over the forecast period. Furthermore, the increasing demand for DNA diagnostics/testing is driven by the rising demand for prenatal testing, and in-vitro fertilization is expected to provide positive growth prospects to the market. In September 2022, Eurofins Genoma announced the launch of niPGT-A, an embryo-free, non-invasive preimplantation screening test.

DNA diagnostics enables the comprehensive analysis of tumor genomes through techniques such as next-generation sequencing (NGS). NGS allows for the simultaneous sequencing of multiple genes, providing a detailed view of the genetic alterations present in the tumor. By comparing the tumor genome with normal tissue DNA, scientists and clinicians can identify specific mutations, copy number variations, and structural rearrangements unique to the cancer cells. In June 2022, Illumina, a DNA sequencing and array-based technology provider, introduces a research test developed in collaboration with Merck, aimed at unlocking deeper insights into the tumor genome.

Hepatitis C virus (HCV) is a global health concern, affecting millions of people worldwide. Accurate and timely diagnosis of HCV is crucial for effective treatment and prevention of further transmission. In this context, DNA diagnostics has emerged as a powerful tool for detecting and managing HCV infections. In July 2022, Roche introduced a groundbreaking dual antigen and antibody diagnostic test Elecsys HCV Duo, to aid the global efforts in eradicating the hepatitis C virus.

DNA Diagnostics Market Report Highlights:

  • The PCR-based diagnostics segment held the largest share of 49.40% in 2024, the dominance of this segment can be attributed to the widespread market usage and the increase in product availability due to the rising number of key players introducing innovative PCR-based diagnostics
  • NGS DNA diagnosis is projected to grow fastest CAGR of 13.9% over the forecast period owing to advancements in high-throughput sequencing technologies that enable comprehensive genetic analyses.
  • Cancer genetics tests segment held the largest share of 29.80% in 2024. DNA sequencing technologies are increasingly utilized to identify and characterize various cancer types and genetic disorders.
  • North America DNA diagnostics market dominated the overall global market and accounted for the 42.72% revenue share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Application
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Application outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. DNA Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. DNA Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. DNA Diagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. DNA Diagnostics Market: Technology Movement Analysis
  • 4.3. DNA Diagnostics Market by Technology Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. PCR-based Diagnostics
    • 4.5.1. PCR-based Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. NGS DNA Diagnosis
    • 4.6.1. NGS DNA Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. In-Situ Hybridization Diagnostics
    • 4.7.1. In-Situ Hybridization Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Microarrays-based Diagnostics
    • 4.8.1. Microarrays-based Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Other Technologies
    • 4.9.1. In Other Technologies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. DNA Diagnostics Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. DNA Diagnostics Market: Application Movement Analysis
  • 5.3. DNA Diagnostics Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Cancer Genetics Tests
    • 5.5.1. Cancer Genetics Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Infectious Diseases DNA Testing
    • 5.6.1. Infectious Diseases DNA Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. HBV Diagnostic
      • 5.6.2.1. HBV Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. TB Diagnostic
      • 5.6.3.1. TB Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. CT/NG Diagnostic
      • 5.6.4.1. CT/NG Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. HPV Diagnostic
      • 5.6.5.1. HPV Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.6. MRSA Diagnostic
      • 5.6.6.1. MRSA Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.7. Others
      • 5.6.7.1. Others Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Newborn Genetic Screening
    • 5.7.1. Newborn Genetic Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Preimplantation & Reproductive Diagnosis
    • 5.8.1. Preimplantation & Reproductive Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Non-Infectious Diseases DNA Testing
    • 5.9.1. Non-Infectious Diseases DNA Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.2. Cardiovascular Diseases
      • 5.9.2.1. Cardiovascular Diseases Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.3. CNS & PNS Related
      • 5.9.3.1. CNS & PNS Related Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.4. Skeletal, Connective, Ectodermal & Dermal DNA Testing
      • 5.9.4.1. Skeletal, Connective, Ectodermal & Dermal DNA Testing Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.5. Lung, Kidney, Liver & GT Related
      • 5.9.5.1. Lung, Kidney, Liver & GT Related Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.6. Sensory Diseases
      • 5.9.6.1. Sensory Diseases Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Prenatal DNA Carrier Screening
    • 5.10.1. Prenatal DNA Carrier Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Pharmacogenomics/Drug Metabolism
    • 5.11.1. Pharmacogenomics/Drug Metabolism Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.12. Hematology & Immunology/Identity Diagnostics & Forensics
    • 5.12.1. Hematology & Immunology/Identity Diagnostics & Forensics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.13. Others
    • 5.13.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. DNA Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Regional DNA Diagnostics Market movement analysis
  • 6.3. DNA Diagnostics Market: Regional Estimates & Trend Analysis by Technology, Biomaterial & End-use
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. North America
    • 6.5.1. North America DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. U.S. DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.2.2. Key Country Dynamics
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Scenario
      • 6.5.2.5. Competitive Scenario
    • 6.5.3. Canada
      • 6.5.3.1. Canada DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.3.2. Key Country Dynamics
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Scenario
      • 6.5.3.5. Competitive Scenario
    • 6.5.4. Europe
    • 6.5.5. Europe DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. UK
      • 6.5.6.1. UK DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.6.2. Key Country Dynamics
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Scenario
      • 6.5.6.5. Competitive Scenario
    • 6.5.7. Germany
      • 6.5.7.1. Germany DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.7.2. Key Country Dynamics
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Scenario
      • 6.5.7.5. Competitive Scenario
    • 6.5.8. France
      • 6.5.8.1. France DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.8.2. Key Country Dynamics
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Scenario
      • 6.5.8.5. Competitive Scenario
    • 6.5.9. Italy
      • 6.5.9.1. Italy DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.9.2. Key Country Dynamics
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Scenario
      • 6.5.9.5. Competitive Scenario
    • 6.5.10. Spain
      • 6.5.10.1. Spain DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.10.2. Key Country Dynamics
      • 6.5.10.3. Regulatory Framework
      • 6.5.10.4. Reimbursement Scenario
      • 6.5.10.5. Competitive Scenario
    • 6.5.11. Denmark
      • 6.5.11.1. Denmark DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.11.2. Key Country Dynamics
      • 6.5.11.3. Regulatory Framework
      • 6.5.11.4. Reimbursement Scenario
      • 6.5.11.5. Competitive Scenario
    • 6.5.12. Norway
      • 6.5.12.1. Norway DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.12.2. Key Country Dynamics
      • 6.5.12.3. Regulatory Framework
      • 6.5.12.4. Reimbursement Scenario
      • 6.5.12.5. Competitive Scenario
    • 6.5.13. Sweden
      • 6.5.13.1. Sweden DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.13.2. Key Country Dynamics
      • 6.5.13.3. Regulatory Framework
      • 6.5.13.4. Reimbursement Scenario
      • 6.5.13.5. Competitive Scenario
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Japan DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.2.2. Key Country Dynamics
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Scenario
      • 6.6.2.5. Competitive Scenario
    • 6.6.3. China
      • 6.6.3.1. China DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.3.2. Key Country Dynamics
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Scenario
      • 6.6.3.5. Competitive Scenario
    • 6.6.4. India
      • 6.6.4.1. India DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.4.2. Key Country Dynamics
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Scenario
      • 6.6.4.5. Competitive Scenario
    • 6.6.5. South Korea
      • 6.6.5.1. South Korea DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.5.2. Key Country Dynamics
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Scenario
      • 6.6.5.5. Competitive Scenario
    • 6.6.6. Australia
      • 6.6.6.1. Australia DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.6.2. Key Country Dynamics
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Scenario
      • 6.6.6.5. Competitive Scenario
    • 6.6.7. Thailand
      • 6.6.7.1. Thailand DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.7.2. Key Country Dynamics
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Scenario
      • 6.6.7.5. Competitive Scenario
  • 6.7. Latin America
    • 6.7.1. Latin America DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.2.1. Brazil DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.2.2. Key Country Dynamics
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Scenario
      • 6.7.2.5. Competitive Scenario
    • 6.7.3. Argentina
      • 6.7.3.1. Argentina DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.3.2. Key Country Dynamics
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Scenario
      • 6.7.3.5. Competitive Scenario
    • 6.7.4. Mexico
      • 6.7.4.1. Mexico DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.4.2. Key Country Dynamics
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Reimbursement Scenario
      • 6.7.4.5. Competitive Scenario
  • 6.8. Middle East & Africa
    • 6.8.1. Middle East & Africa DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. South Africa DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.8.2.2. Key Country Dynamics
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Scenario
      • 6.8.2.5. Competitive Scenario
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Saudi Arabia DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.8.3.2. Key Country Dynamics
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Scenario
      • 6.8.3.5. Competitive Scenario
    • 6.8.4. UAE
      • 6.8.4.1. UAE DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.8.4.2. Key Country Dynamics
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Scenario
      • 6.8.4.5. Competitive Scenario
    • 6.8.5. Kuwait
      • 6.8.5.1. Kuwait DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.8.5.2. Key Country Dynamics
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Scenario
      • 6.8.5.5. Competitive Scenario

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Company Categorization
  • 7.3. Strategy Mapping
    • 7.3.1. NEW PRODUCT LAUNCH
    • 7.3.2. PARTNERSHIPS
    • 7.3.3. ACQUISITION
    • 7.3.4. COLLABORATION
  • 7.4. Key Company Market Share Analysis, 2024
  • 7.5. Key Company Profiles
    • 7.5.1. Abbott
      • 7.5.1.1. Company overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Technology benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. F. Hoffmann-La Roche Ltd.
      • 7.5.2.1. Company overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Technology benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. QIAGEN
      • 7.5.3.1. Company overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Technology benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. Bio-Rad Laboratories, Inc.
      • 7.5.4.1. Company overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Technology benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. Thermo Fisher Scientific, Inc.
      • 7.5.5.1. Company overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Technology benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. Illumina, Inc.
      • 7.5.6.1. Company overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Technology benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. Hologic, Inc.
      • 7.5.7.1. Company overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Technology benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Agilent Technologies Inc.
      • 7.5.8.1. Company overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Technology benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Siemens Healthineers AG
      • 7.5.9.1. Company overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Technology benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. Danaher Corporation
      • 7.5.10.1. Company overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Technology benchmarking
      • 7.5.10.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 4. Global DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 5. North America DNA diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 6. North America DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 7. North America DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 8. U.S. DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 9. U.S. DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 10. Canada DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 11. Canada DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 12. Mexico DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 13. Mexico DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 14. Europe DNA diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 15. Europe DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 16. Europe DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 17. UK DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18. UK DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 19. Germany DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 20. Germany DNA diagnostics market, by application 2018 - 2030 (USD Million)
  • Table 21. France DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22. France DNA diagnostics market, by application 2018 - 2030 (USD Million)
  • Table 23. Italy DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 24. Italy DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 25. Spain DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 26. Spain DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 27. Denmark DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 28. Denmark DNA diagnostics market, by application 2018 - 2030 (USD Million)
  • Table 29. Norway DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 30. Norway DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 31. Sweden DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 32. Sweden DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific DNA diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 36. Japan DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 37. Japan DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 38. China DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 39. China DNA diagnostics market, by application 2018 - 2030 (USD Million)
  • Table 40. India DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 41. India DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 42. Australia DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43. Australia DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 44. South Korea DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 45. South Korea DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 46. Thailand DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47. Thailand DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 48. Latin America DNA diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 49. Latin America DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 50. Latin America DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 51. Brazil DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 52. Brazil DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 53. Argentina DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 54. Argentina DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 55. Middle East & Africa DNA diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 58. South Africa DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 59. South Africa DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 60. Saudi Arabia DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 62. UAE DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 63. UAE DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 64. Kuwait DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 65. Kuwait DNA diagnostics market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 DNA diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Technology snapshot
  • Fig. 10 Application snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market value, 2024 (USD Million)
  • Fig. 13 Market dynamics
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 DNA diagnostics market: Technology outlook and key takeaways
  • Fig. 17 DNA diagnostics market: Technology movement analysis
  • Fig. 18 PCR-based diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Microarrays-based diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 In-situ hybridization diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 NGS DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Other technologies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 DNA diagnostics market: Application outlook and key takeaways
  • Fig. 24 DNA diagnostics market: Application movement analysis
  • Fig. 25 Cancer genetics tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Infectious diseases DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 HBV diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 TB diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 CT/NG diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 HPV diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 MRSA diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Other infectious diseases DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Newborn genetic screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Preimplantation & reproductive diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Non-infectious diseases DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Cardiovascular diseases diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 CNS & PNS related market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Skeletal, connective, ectodermal & dermal DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Lung, kidney, liver & GT related market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Sensory diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Prenatal DNA carrier screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Pharmacogenomics/drug metabolism market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Hematology & immunology/identity diagnostics & forensics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 DNA diagnostics market revenue, by region, 2024 & 2030 (USD Million)
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 Regional marketplace: Key takeaways
  • Fig. 48 North America DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 U.S. DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Canada DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Mexico DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Europe DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 UK DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Germany DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 France DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Italy DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Denmark DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Sweden DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Norway DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Rest of Europe DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Asia Pacific DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Japan DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 China DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 China regulatory details
  • Fig. 79 Key country dynamics
  • Fig. 80 India DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Australia DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Thailand DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 South Korea DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 South Korean regulations in four hierarchical orders
  • Fig. 88 Rest of Asia Pacific DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Latin America DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Brazil DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Argentina DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Rest of Latin America DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 MEA DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 South Africa DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Saudi Arabia DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 UAE DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Kuwait DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 Rest of MEA DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key company categorization
  • Fig. 106 Heat map analysis
  • Fig. 107 Strategic framework